https://www.selleckchem.com/pr....oducts/mi-773-sar405
Tacrolimus has been used to treat various inflammatory skin diseases, but its safety for topical application on the oral mucosa is unknown. Exfoliative cheilitis (EC) is a chronic inflammatory disorder of the lips characterised by repeated scaling; it is difficult to manage. The aim of this study was to assess the efficacy and safety of tacrolimus 0.03% ointment as a topical treatment in patients with EC. In this randomised controlled clinical trial, 40 patients with EC were randomly assigned to receive either tacrolimus 0.03%
Like
Comment
Share
